Home
Accretion Pharmaceuticals Ltd Share Price History
NSE : 21 May, 2025
82.95-18.0 (-17.9%)
Prev Close
101.0
Open Price
79.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
0
Today's High / Low
82.9 / 75.1
52 WK High / Low
82.9 / 75.1
Market Price of Accretion Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Accretion Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2024 |
|---|---|
| Sales (Cr.) | 13 |
| Sales YoY Gr. | - |
| Adj EPS | 8.96 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 13.73 |
Key Financial Parameters
| Parameter | 2024 |
|---|---|
| Return on Capital Emp. % | 31.12 |
| Op. Profit Mgn % | 20.15 |
| Net Profit Mgn % | 11.16 |
| Debt to Equity % | 2.46 |
Latest Shareholding
Promoters Holdings Over Time
About Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
- Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014.
- Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Accretion Pharmaceuticals Ltd's share price history?
Key events that impact Accretion Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Accretion Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Accretion Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Accretion Pharmaceuticals Ltd?
Dividends can influence Accretion Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Accretion Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Accretion Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Accretion Pharmaceuticals Ltd’s share price history?
To understand Accretion Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
